Exact Mass: 587.3094

Exact Mass Matches: 587.3094

Found 424 metabolites which its exact mass value is equals to given mass value 587.3094, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Lipomycin

alpha-Lipomycin

C32H45NO9 (587.3094)

Cholyl-L-dopa

3-(3,4-Dihydroxyphenyl)-2-[(1-hydroxy-4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}pentylidene)amino]propanoate

C33H49NO8 (587.3458)

Glu-Ile-Leu-Asp-Val

4-Amino-4-[(1-{[1-({2-carboxy-1-[(1-carboxy-2-methylpropyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)-3-methylbutyl]-C-hydroxycarbonimidoyl}-2-methylbutyl)-C-hydroxycarbonimidoyl]butanoate

C26H45N5O10 (587.3166)

H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH

1-{2-[(2-{[2-({2-[(2-amino-1-hydroxyethylidene)amino]-5-carbamimidamido-1-hydroxypentylidene}amino)-1-hydroxyethylidene]amino}-3-carboxy-1-hydroxypropylidene)amino]-3-hydroxypropanoyl}pyrrolidine-2-carboxylate

C22H37N9O10 (587.2663)

GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor.

Retaspimycin

({13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-[(prop-2-en-1-yl)amino]-2-azabicyclo[16.3.1]docosa-1(22),4,6,10,18,20-hexaen-9-yl}oxy)methanimidate

C31H45N3O8 (587.3206)

Pseudojervine

3beta-(D-glucopyranosyloxy)-jervine

C33H49NO8 (587.3458)

Origin: Plant; SubCategory_DNP: Steroidal alkaloids, Veratrum alkaloids Annotation level-1

Ludaconitine

Glu Leu Gly Lys Gln

C25H45N7O9 (587.3279)

Glu Gln Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C22H41N11O8 (587.3139)

Gly Lys Gln Leu Glu

C25H45N7O9 (587.3279)

Pseudojervin

IIDDI

Ile Ile Asp Asp Ile

C26H45N5O10 (587.3166)

QAQIE

Gln-Ala-Gln-Ile-Glu

C24H41N7O10 (587.2915)

alpha,alpha-bis[4-(diethylamino)phenyl]-4-[(4-ethoxyphenyl)amino]naphthalene-1-methanol

C39H45N3O2 (587.3512)

SCH772984

(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide

C33H33N9O2 (587.2757)

SCH772984 is a highly selective and ATP-competitive ERK inhibitor, with IC50s of 4 and 1 nM for ERK1 and ERK2, respectively. SCH772984 has antitumor activity in MAPK inhibitor-na?ve and MAPK inhibitor-resistant cells containing BRAF or RAS mutations[1].

Retaspimycin

C31H45N3O8 (587.3206)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

5-(4-Aminobutoxy)-N,N,N,N-tetrakis(2-pyridinylmethyl)-1,3-benzenedimethanamine

C36H41N7O (587.3372)

H-DL-Glu-DL-xiIle-DL-Leu-DL-Asp-DL-Val-OH

C26H45N5O10 (587.3166)

(3R,3aS,6S,6bS,9R,11aS)-3,6,10,11b-tetramethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one

(3R,3aS,6S,6bS,9R,11aS)-3,6,10,11b-tetramethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one

C33H49NO8 (587.3458)

(3S,3R,3aS,6S,6bS,9R,11aS,11bR)-3,6,10,11b-tetramethyl-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one

(3S,3R,3aS,6S,6bS,9R,11aS,11bR)-3,6,10,11b-tetramethyl-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one

C33H49NO8 (587.3458)

(3R,3aS,6bS,7aR,9R,11aS)-3,6,10,11b-tetramethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one

(3R,3aS,6bS,7aR,9R,11aS)-3,6,10,11b-tetramethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one

C33H49NO8 (587.3458)

[(2S)-1-oxo-1-[[(2S,10R,12S,14S)-12,16,19-trihydroxy-7,14,18-trimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methylamino]propan-2-yl]azanium

[(2S)-1-oxo-1-[[(2S,10R,12S,14S)-12,16,19-trihydroxy-7,14,18-trimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methylamino]propan-2-yl]azanium

C29H39N4O9+ (587.2717)

[(4E,6Z,10E)-13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate

C31H45N3O8 (587.3206)

Cholyl-L-dopa

C33H49NO8 (587.3458)

Dinoflagellate luciferin(1-)

(3S,3aS,7aR,9R)-3,6,10,11b-tetramethyl-3-[(2R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one

An organic cation that is the conjugate acid of pipacycline.

PC(22:3)

PC(4:0_18:3)

C30H54NO8P (587.3587)

MePC(21:3)

C33H49NO8 (587.3458)

(3s,3'as,7'ar,9r)-3',6',10,11b-tetramethyl-3-{[(2r,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

(3s,3'as,7'ar,9r)-3',6',10,11b-tetramethyl-3-{[(2r,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11a-hexadecahydro-3'h-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-11-one

C33H49NO8 (587.3458)

(3r,9s,12s,18s)-9-benzyl-5,8,11,14,17-pentahydroxy-12-isopropyl-3,18-bis(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclooctadeca-4,7,10,13,16-pentaen-2-one

C30H45N5O7 (587.3319)

(2s)-1-[(3s,7s,10s,13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-(1h-indol-3-yl)propan-1-one

(2s)-1-[(3s,7s,10s,13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-(1h-indol-3-yl)propan-1-one

C33H41N5O5 (587.3108)

(1s,2r,3r,4r,5s,6s,8s,9s,10r,13s,16s,17s)-11-ethyl-5,8,17-trihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C32H45NO9 (587.3094)

(1-{[(1s)-1-[(1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}-2-(4-hydroxyphenyl)ethyl)trimethylazanium

(1-{[(1s)-1-[(1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}-2-(4-hydroxyphenyl)ethyl)trimethylazanium

[C30H43N4O8]+ (587.3081)

(1r,2r,3r,4s,5s,6s,8s,9r,10s,13s,14r,16r,17r)-11-ethyl-5,8,14-trihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C32H45NO9 (587.3094)

(2r,5s,8s,11s,15r)-11-benzyl-3,12-dihydroxy-10,15-dimethyl-2,5,8-tris(2-methylpropyl)-1,7-dioxa-4,10,13-triazacyclohexadeca-3,12-diene-6,9,16-trione

C32H49N3O7 (587.357)

(1r,3r,4s,5r,8s,9r,10r,11r,14r,16s,17r,18r,19r)-4,10,19-tris(acetyloxy)-9,18-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl (2r)-2-methylbutanoate